Nalaganje...
Loss of Pten synergizes with c-Met to promote hepatocellular carcinoma development via mTORC2 pathway
Hepatocellular carcinoma (HCC) is a deadly malignancy with limited treatment options. Activation of the AKT/mTOR cascade is one of the most frequent events along hepatocarcinogenesis. mTOR is a serine/threonine kinase and presents in two distinct complexes: mTORC1 and mTORC2. While mTORC1 has been e...
Shranjeno v:
| izdano v: | Exp Mol Med |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5992985/ https://ncbi.nlm.nih.gov/pubmed/29303510 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emm.2017.158 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|